The Latest Breaking News from AstraZeneca

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.

China’s president Xi Jinping recently held a meeting with 40 leaders of multinational companies, including BMW and AstraZeneca.

Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

"It's like being drained of vitality." Scientists discovered a new syndrome linked to the COVID-19 vaccines that may cause persistent biological changes and chronic flu-like symptoms. The post Yale Scientists Link Covid Vaccines To Alarming New Syndrome With Long-Term Effects first appeared on Bored Panda.

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024.

The pharmaceutical and biotech industries are brimming with potential. From revolutionary cancer treatments to cutting-edge gene-editing breakthroughs, start-ups in this space have the power to transform medicine and save lives.

When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate Devlin question why it fell through